Patent Applications published on Nov 4, 2021 - page 4

#901 ✅ Patent 11,759,442 granted on 2023-09-19
US20210338614A1
Human necessities

Use of short chain fatty acids for the treatment and prevention of diseases and disorders

#902
US20210338615A1
Human necessities

Inhibition of Acetyl-CoA Metabolism for Treatment and Prevention of Immune System Diseases and Disorders

#903
US20210338616A1
Human necessities

LIQUID DOSAGE FORMS OF SODIUM NAPROXEN

#904
US20210338617A1
Human necessities

Compositions and Methods for Treating Chronic Inflammation and Inflammatory Diseases

#905 ✅ Patent 11,890,264 granted on 2024-02-06
US20210338618A1
Human necessities

Migraine prevention and treatment

#906 ✅ Patent 12,150,924 granted on 2024-11-26
US20210338619A1
Human necessities

Compositions and methods for treating autism

#907 ✅ Patent 11,648,224 granted on 2023-05-16
US20210338620A1
Human necessities

Use and method of L-aspartic acid beta-hydroxamate in preparing drugs for inhibiting choroidal neovascularization

#908
US20210338621A1
Human necessities

USE OF NICOTINIC ACETYLCHOLINE RECEPTOR ALPHA 7 ACTIVATORS

#909 ✅ Patent 12,150,926 granted on 2024-11-26
US20210338622A1
Human necessities

Use of chlorogenic acid composition thereof in preparation of medicament for treating sarcoma

#910 ✅ Patent 11,957,653 granted on 2024-04-16
US20210338623A1
Human necessities

Compositions comprising N-acetyl methyl GABA and related methods

#911 ✅ Patent 12,290,500 granted on 2025-05-06
US20210338624A1
Human necessities

Anaplerotic agents for treatment of disorders of propionate and long chain fat metabolism

#912
US20210338625A1
Human necessities

USE OF POLYOL FATTY ESTER COMPOSITIONS AND PRODUCTS FOR MINIMIZING EXPOSURE TO A NOXIOUS SUBSTANCE

#913
US20210338626A1
Human necessities

METHODS FOR TREATING OR PREVENTING A VIRAL INFECTION OR INHIBITING VIRAL REPLICATION

#914 ✅ Patent 12,268,661 granted on 2025-04-08
US20210338627A1
Human necessities

Methods of treating ascites

#915 ✅ Patent 11,865,101 granted on 2024-01-09
US20210338628A1
Human necessities

Cromolyn metal complexes as enhanced pharmaceutical formulations and method of preparing the same

#916
US20210338629A1
Human necessities

ORAL FORMULATIONS OF PHENYLALANINE AND CANNABINOIDS

#917
US20210338630A1
Human necessities

METHODS TO TREAT RENAL DISORDERS USING CALCIUM CHANNEL INHIBITORS

#918 ✅ Patent 11,903,921 granted on 2024-02-20
US20210338631A1
Human necessities

Systems and methods for treating coronavirus

#919 ✅ Patent 12,070,443 granted on 2024-08-27
US20210338632A1
Human necessities

Methods of treating and preventing breast cancer with S-equol

#920
US20210338633A1
Human necessities

METHOD FOR EVALUATING THE ABILITY OF A COMPOSITION TO PREVENT MUSCLE DAMAGE AND FATIGUE; FOOD SUPPLEMENT AND DRUG

#921
US20210338634A1
Human necessities

PUTRESCINE SLOW-RELEASE TOPICAL FORMULATIONS

#922
US20210338635A1
Human necessities

Dosage Regimen for the Treatment of Multiple Sclerosis with a S1P Receptor Modulator

#923 ✅ Patent 11,896,578 granted on 2024-02-13
US20210338636A1
Human necessities

Methods of treating conditions related to the S1Preceptor

#924
US20210338637A1
Human necessities

INDOLE DERIVATIVES FOR BIOFILM DISRUPTION AND INHIBITION

#925 ✅ Patent 11,717,510 granted on 2023-08-08
US20210338638A1
Human necessities

Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance

#926
US20210338639A1
Human necessities

METHODS OF TREATING COGNITIVE IMPAIRMENT OR IMPROVING COGNITIVE FUNCTION

#927 ✅ Patent 11,672,783 granted on 2023-06-13
US20210338640A1
Human necessities

Pharmaceutical combination comprising a selective S1P1 receptor agonist

#928 ✅ Patent 11,369,590 granted on 2022-06-28
US20210338641A1
Human necessities

PSMA binding ligand-linker conjugates and methods for using

#929
US20210338642A1
Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF PULMONARY HYPERTENSION

#930 ✅ Patent 11,590,113 granted on 2023-02-28
US20210338643A1
Human necessities

Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator

#931
US20210338644A1
Human necessities

Substituted Fused Imidazole Derivatives and Methods of Treating Sickle Cell Disease and Related Complications

#932
US20210338645A1
Human necessities

SOLID DISPERSION OF RIFAMYCIN-NITROIMIDAZOLE COUPLING MOLECULE AND APPLICATION THEREOF

#933
US20210338646A1
Human necessities

METHOD FOR TREATING MOVEMENT DISORDERS WITH BEFIRADOL

#934
US20210338647A1
Human necessities

Combination of Acetylcholinesterase Inhibitor and 5-HT4 Receptor Agonist As Neuroprotective Agent In the Treatment of Neurodegenerative Diseases

#935
US20210338648A1
Human necessities

METHODS AND COMPOSITIONS FOR REDUCING SERUM URIC ACID

#936
US20210338649A1
Human necessities

NIMODIPINE INJECTION COMPOSITION AND PREPARATION METHOD THEREFOR

#937
US20210338650A1
Human necessities

CXCL10 Inhibitors

#938 ✅ Patent 12,097,193 granted on 2024-09-24
US20210338651A1
Human necessities

Methods for the administration of COMT inhibitors

#939
US20210338652A1
Human necessities

COMPOSITION AND USE FOR THE TREATMENT OF PARKINSON'S DISEASE AND RELATED DISORDERS

#940
US20210338653A1
Human necessities

N-[2-(1 -BENZYLPIPERIDIN-4-YL)ETHYL]-4-(PYRAZIN-2-YL)-PIPERAZINE-1 -CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS MUSCARINIC RECEPTOR 4 (M4) ANTAGONISTS FOR TREATING NEUROLOGICAL DISEASES

#941
US20210338654A1
Human necessities

CGRP ANTAGONISTS FOR TREATING MIGRAINE BREAKTHROUGH

#942 ✅ Patent 12,138,254 granted on 2024-11-12
US20210338655A1
Human necessities

Chronic nightly dosing of lasmiditan for migraine prevention

#943
US20210338656A1
Human necessities

IMMUNOSTIMULATORY AGENTS IN COMBINATION WITH ANGIOGENESIS INHIBITORS

#944
US20210338657A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING IRON OVERLOAD

#945
US20210338658A1
Human necessities

MACROLIDE COMPOUNDS AND THEIR USE IN LIVER STAGE MALARIA AND RELATED DISEASE

#946 ✅ Patent 12,064,425 granted on 2024-08-20
US20210338659A1
Human necessities

Compositions and methods for targeting a viral infection

#947 ✅ Patent 11,974,996 granted on 2024-05-07
US20210338660A1
Human necessities

Naloxegol oxalate and solid dispersion thereof

#948
US20210338661A1
Human necessities

NEW USES OF A PURE 5-HT 6 RECEPTOR ANTAGONIST

#949
US20210338662A1
Human necessities

ALPHA-2-ADRENOCEPTOR SUBTYPE C (ALPHA-2C) ANTAGONISTS FOR THE TREATMENT OF SLEEP APNEA

#950
US20210338663A1
Human necessities

CONTROLLED RELEASE STERILE INJECTABLE ARIPIPRAZOLE FORMULATION AND METHOD

#951 ✅ Patent 11,364,239 granted on 2022-06-21
US20210338664A1
Human necessities

Compositions and methods for mitigating aflatoxin B1-induced liver injury

#952
US20210338665A1
Human necessities

MEDICAL USE OF PROSTACYCLIN RECEPTOR AGONIST

#953
US20210338666A1
Human necessities

BRIMONIDINE COMBINATIONS AND USES THEREOF

#954 ✅ Patent 11,883,400 granted on 2024-01-30
US20210338667A1
Human necessities

Treatment of portal hypertension and cirrhosis

#955 ✅ Patent 11,369,605 granted on 2022-06-28
US20210338668A1
Human necessities

Optically active azabicyclo ring derivative

#956 ✅ Patent 11,844,801 granted on 2023-12-19
US20210338669A1
Human necessities

Oral compositions of MK2 pathway inhibitor for treatment of immune conditions

#957 ✅ Patent 12,090,157 granted on 2024-09-17
US20210338670A1
Human necessities

Non-invasive pet imaging of CDK4/6 activation in cancer

#958
US20210338671A1
Human necessities

COMPOSITIONS OF SURFACE-MODIFIED THERAPEUTICALLY ACTIVE PARTICLES BY ULTRA-RAPID FREEZING

#959
US20210338672A1
Human necessities

USE OF AN INHIBITOR OF AN ENT FAMILY TRANSPORTER IN THE TREATMENT OF CANCER AND COMBINATION THEREOF WITH AN ADENOSINE RECEPTOR ANTAGONIST

#960
US20210338673A1
Human necessities

MNK INHIBITORS AND METHODS RELATED THERETO

#961
US20210338674A1
Human necessities

COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING DISORDERS ASSOCIATED WITH THE 5-HT1A AND 5-HT2A RECEPTORS

#962 ✅ Patent 12,246,019 granted on 2025-03-11
US20210338675A1
Human necessities

Alpha polyglutamated lometrexol and uses thereof

#963 ✅ Patent 11,679,111 granted on 2023-06-20
US20210338676A1
Human necessities

Fatty acid synthase inhibitors

#964 ✅ Patent 11,766,438 granted on 2023-09-26
US20210338677A1
Human necessities

Pharmaceutical compositions of tofacitinib for oral administration

#965
US20210338678A1
Human necessities

BIOACTIVE VITAMIN COMBINATIONS

#966
US20210338679A1
Human necessities

NOVEL USES

#967 ✅ Patent 12,042,496 granted on 2024-07-23
US20210338680A1
Human necessities

Methods related to opioid therapeutics

#968
US20210338681A1
Human necessities

COMBINATION THERAPIES

#969
US20210338682A1
Human necessities

METHOD OF TREATING PATIENTS COADMINISTERED A FACTOR Xa INHIBITOR AND VERAPAMIL

#970
US20210338683A1
Human necessities

TREATMENT OF VIRAL INFECTIONS WITH COMBINATION OF PIKFYVE KINASE INHIBITORS AND TMPRSS-2 INHIBITORS

#971
US20210338684A1
Human necessities

DIAGNOSTIC AND THERAPEUTIC METHODS FOR CANCER

#972
US20210338685A1
Human necessities

AGENTS AND METHODS FOR MODULATING PATHOGEN ACTIVITY

#973
US20210338686A1
Human necessities

COMBINATION CANCER THERAPY WITH PENTAAZA MACROCYCLIC RING COMPLEX AND PLATINUM-BASED ANTICANCER AGENT

#974
US20210338687A1
Human necessities

MIFEPRISTONE ORAL FORM FOR ITS USE IN CERVIX RIPENING AND LABOUR INDUCTION

#975 ✅ Patent 12,208,104 granted on 2025-01-28
US20210338688A1
Human necessities

Pharmaceutical compositions suitable for articular delivery and use thereof in treatment of joint pain

#976 ✅ Patent 12,048,705 granted on 2024-07-30
US20210338689A1
Human necessities

Immunoablative therapies

#977
US20210338690A1
Human necessities

COMPOUNDS AND METHODS FOR PREVENTION AND TREATMENT OF CORONAVIRUS INFECTIONS

#978
US20210338691A1
Human necessities

METHODS FOR TREATING SLEEP DISORDERS, SLEEP DISTURBANCES, AND RELATED SYMPTOMS USING AMINOSTEROL COMPOSITIONS

#979
US20210338692A1
Human necessities

A 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID AND METHODS OF USE THEREOF

#980
US20210338693A1
Human necessities

Gel Compositions for Transdermal Delivery to Maximize Drug Concentrations in the Stratum Corneum and Serum and Methods of Use Thereof

#981
US20210338694A1
Human necessities

SOS1 ALLOSTERIC SITE TARGETING

#982 ✅ Patent 11,504,385 granted on 2022-11-22
US20210338695A1
Human necessities

Proteolysis targeting chimeric molecule, preparation method, and application

#983 ✅ Patent 11,801,255 granted on 2023-10-31
US20210338696A1
Human necessities

Lipid disulfide prodrugs and uses related thereto

#984 ✅ Patent 12,076,333 granted on 2024-09-03
US20210338697A1
Human necessities

Lysophosphatidylcholine compositions

#985 ✅ Patent 11,141,419 granted on 2021-10-12
US20210338698A1
Human necessities

Use of iminosugars as prophylactic and therapy against COVID-19 / SARS-CoV-2

#986
US20210338699A1
Human necessities

MATERIALS AND METHODS FOR SUPPRESSING AND/OR TREATING CANCER AND/OR CANCER TREATMENT INDUCED CARDIAC TOXICITY

#987 ✅ Patent 12,257,260 granted on 2025-03-25
US20210338700A1
Human necessities

Pharmaceutical use of anemoside B4 against acute gouty arthritis

#988
US20210338701A1
Human necessities

DNA HYPOMETHYLATING AGENTS FOR CANCER THERAPY

#989
US20210338702A1
Human necessities

A teniposide injection with high dilution stability and preparation method thereof

#990
US20210338703A1
Human necessities

PROCESS FOR THE ISOLATION OF NOVEL GLYCOSIDES FROM PTEROCARPUS MARSUPIUM AND THEIR THERAPEUTIC EFFECTS

#991 ✅ Patent 12,064,445 granted on 2024-08-20
US20210338704A1
Human necessities

Cytarabine conjugates for cancer therapy

#992
US20210338705A1
Human necessities

ENCAPSULATION AND HIGH ENCAPSULATION EFFICIENCY OF PHOSPHORYLATED ACTIVE AGENTS IN NANOPARTICLES

#993
US20210338706A1
Human necessities

ADENOSINE ANALOG AND ITS USE IN REGULATING THE CIRCADIAN CLOCK

#994
US20210338707A1
Human necessities

HIGH CONCENTRATION FORMULATIONS

#995
US20210338708A1
Human necessities

METHOD FOR TREATMENT OF CORONAVIRUS INFECTION

#996
US20210338709A1
Human necessities

USES OF MODIFIED RNA ENCODING RETINALDEHYDE DEHYDROGENASE

#997 ✅ Patent 11,980,637 granted on 2024-05-14
US20210338710A1
Human necessities

Compositions comprising nanosilica particles and their use in methods of activating T lymphocytes for therapy

#998
US20210338711A1
Human necessities

AQUEOUS ANTI MICROBIAL COMPOSITION USEFUL AS A THERAPEUTIC MATERIAL

#999 ✅ Patent 12,029,754 granted on 2024-07-09
US20210338712A1
Human necessities

Adhesive sheet for affixation to body, housed in container

#1000
US20210338713A1
Human necessities

Reduction of Pulmonary Inflammation Using Therapeutic Gas Mixtures

#1001 ✅ Patent 11,738,043 granted on 2023-08-29
US20210338714A1
Human necessities

Sodium chlorite compositions with enhanced antimicrobial efficacy and reduced toxicity

#1002
US20210338715A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF COVID-19

#1003
US20210338716A1
Human necessities

Sodium Chlorite Compositions with Enhanced Anti-Viral and Anti-Microbial Efficacy and Reduced Toxicity

#1004
US20210338717A1
Human necessities

NANOPARTICLE DELIVERY TO A TARGET TISSUE

#1005
US20210338718A1
Human necessities

METHODS FOR PREVENTING AND TREATING PULMONARY INFLAMMATION AND FIBROSIS

#1006
US20210338719A1
Human necessities

COMPOSITION COMPRISING FERROUS SULPHATE MONOHYDRATE AND LONG CHAIN POLYUNSATURATED FATTY ACIDS

#1007
US20210338720A1
Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENT OF MASTITIS

#1008
US20210338721A1
Human necessities

BIOAVAILABLE MINERALS FOR THE MITIGATION OF PATHOGENS IN ANIMALS, A MANUFACTURING METHOD AND A TREATMENT METHOD

#1009 ✅ Patent 11,903,965 granted on 2024-02-20
US20210338722A1
Human necessities

Methods for preserving and administering pre-beta high density lipoprotein having a predetermined minimum level of degradation

#1010
US20210338723A1
Human necessities

COMPOSITIONS AND METHODS FOR INHIBITING OR SCREENING FOR CD8 AND METHODS AND ASSAYS FOR DETECTING CD8 IN CELLS

#1011 ✅ Patent 12,115,191 granted on 2024-10-15
US20210338724A1
Human necessities

Methods of treating age-related and inflammatory diseases

#1012
US20210338725A1
Human necessities

TREATMENT METHODS

#1013
US20210338726A1
Human necessities

ENGINEERED REGULATORY T CELL

#1014
US20210338727A1
Human necessities

NATURAL KILLER CELL COMPOSITIONS AND IMMUNOTHERAPY METHODS FOR TREATING TUMORS

#1015
US20210338728A1
Human necessities

METHODS AND COMPOSITIONS FOR THE EXPANSION AND USE OF ALLOGENEIC GAMMA/DELTA-T CELLS

#1016
US20210338729A1
Human necessities

CHIMERIC ANTIGEN RECEPTORS (CARs) COMPOSITIONS AND METHODS OF USE THEREOF

#1017
US20210338730A1
Human necessities

Marrow Infiltrating Lymphocytes With Increased Clonality and Uses Thereof

#1018
US20210338731A1
Human necessities

Non-Signaling HIV Fusion Inhibitors And Methods Of Use Thereof

#1019
US20210338732A1
Human necessities

ADOPTIVE CELL TRANSFER AND ONCOLYTIC VIRUS COMBINATION THERAPY

#1020
US20210338733A1
Human necessities

Tn-MUC1 Chimeric Antigen Receptor (CAR) T Cell Therapy

#1021 ✅ Patent 11,918,607 granted on 2024-03-05
US20210338734A1
Human necessities

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#1022 ✅ Patent 11,951,132 granted on 2024-04-09
US20210338735A1
Human necessities

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#1023 ✅ Patent 11,980,641 granted on 2024-05-14
US20210338736A1
Human necessities

Methods for generation of podocytes from pluripotent stem cells and cells produced by the same

#1024
US20210338737A1
Human necessities

TISSUE REPAIR BY ACTIVATED CELLS

#1025
US20210338738A1
Human necessities

CELLS ENGINEERED FOR CO-EXPRESSION OF DECOY RECEPTOR 1 AND TNF-RELATED APOPTOSIS-INDUCING LIGAND AND USES THEREFOR

#1026
US20210338739A1
Human necessities

METHODS OF GENERATING MESENCHYMAL STEM CELLS WHICH SECRETE NEUROTROPHIC FACTORS

#1027
US20210338740A1
Human necessities

THERAPEUTIC METHODS AND COMPOSITIONS

#1028
US20210338741A1
Human necessities

TISSUE HEALING AGENT

#1029
US20210338742A1
Human necessities

HYALURONIC COMPOSITION

#1030 ✅ Patent 12,064,457 granted on 2024-08-20
US20210338743A1
Human necessities

Therapeutic uses of an insect powder

#1031
US20210338744A1
Human necessities

COMPOSITIONS COMPRISING BACTERIAL STRAINS

#1032 ✅ Patent 11,690,879 granted on 2023-07-04
US20210338745A1
Human necessities

, a novel bacterial genus of the gastrointestinal microbiota and uses thereof

#1033
US20210338746A1
Human necessities

COMPOSITIONS COMPRISING BACTERIAL STRAINS

#1034 ✅ Patent 11,896,630 granted on 2024-02-13
US20210338747A1
Human necessities

Composition for a formulated oral prebiotic edible composition

#1035 ✅ Patent 11,324,785 granted on 2022-05-10
US20210338748A1
Human necessities

Composition for preventing or treating menopause, containing

#1036
US20210338749A1
Human necessities

METHODS OF TREATMENT OF INFLAMMATORY CONDITIONS AND ASSOCIATED INFECTIONS

#1037 ✅ Patent 11,612,624 granted on 2023-03-28
US20210338750A1
Human necessities

Method for protecting a subject for exercise

#1038
US20210338751A1
Human necessities

ARTHROSPIRA PLATENSIS NON-PARENTERAL THERAPEUTIC DELIVERY PLATFORM

#1039 ✅ Patent 12,246,047 granted on 2025-03-11
US20210338752A1
Human necessities

Adeno-associated virus purification methods

#1040
US20210338753A1
Human necessities

ONCOLYTIC ADENOVIRUS ENCODING A B7 PROTEIN

#1041
US20210338754A1
Human necessities

HIGH MOBILITY GROUP BOX I MUTANT

#1042
US20210338755A1
Human necessities

AQUEOUS EXTRACT FROM CELLS OF FITZROYA CUPRESSOIDES (ALERCE) WITH ANTI- AGING AND SKIN REGENERATION PROPERTIES

#1043
US20210338756A1
Human necessities

HEALING CREAMS AND FORMULATIONS CONTAINING POMEGRANATE SEED OIL, ROSA CANINA FRUIT OIL, INULA VISCOSA OLEORESIN OR EXTRACT AND OPTIONALLY CITRUS MEDICA VULGARIS ETROG OIL OR EXTRACT

#1044 ✅ Patent 11,986,506 granted on 2024-05-21
US20210338757A1
Human necessities

Dietary supplements for inhibiting PDE5 and increasing cGMP levels

#1045
US20210338758A1
Human necessities

USE OF AT LEAST ONE GLYCYRRHIZA PLANT-BASED PREPARATION, AN ANTIDOTE MADE FROM SAME, AND THE USE OF SAID ANTIDOTE

#1046 ✅ Patent 12,201,664 granted on 2025-01-21
US20210338759A1
Human necessities

Composition for preventing or treating allergic diseases containing mixed extract of two or more among root, root, and as active ingredients

#1047
US20210338760A1
Human necessities

SEBUM CONTROL AND ANTI-ACNE COMPOSITION

#1048
US20210338761A1
Human necessities

COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING SLEEP DISTURBANCE COMPRISING EXTRACT OF FRAXINUS SP. PLANT AS EFFECTIVE COMPONENT

#1049 ✅ Patent 12,036,261 granted on 2024-07-16
US20210338762A1
Human necessities

Compositions and methods of BDNF activation

#1050 ✅ Patent 11,266,707 granted on 2022-03-08
US20210338763A1
Human necessities

Nutraceuticals for the prevention, inhibition, and treatment of SARS-CoV-2 and associated COVID-19

#1051 ✅ Patent 11,590,194 granted on 2023-02-28
US20210338764A1
Human necessities

Topical skin compositions for treating rosacea and skin redness

#1052 ✅ Patent 11,628,197 granted on 2023-04-18
US20210338765A1
Human necessities

Methods and compounds for treating effects of COVID-19 disease

#1053
US20210338766A1
Human necessities

METHODS OF TREATING MULTIPLE MYELOMA

#1054
US20210338767A1
Human necessities

METHODS OF SELECTING TREATMENT FOR CXCR4-ASSOCIATED CANCER

#1055
US20210338768A1
Human necessities

COMPOSITION COMPRISING OIL DROPS

#1056
US20210338769A1
Human necessities

OPHTHALMIC COMPOSITIONS

#1057
US20210338770A1
Human necessities

MEDICAMENT FOR IMPROVING OR PREVENTING SYMPTOMS RELATING TO RETINA AND/OR LIGHT RECEPTION AND METHOD FOR SCREENING FOR SUBSTANCE CAPABLE OF IMPROVING OR PREVENTING SYMPTOMS RELATING TO RETINA AND/OR LIGHT RECEPTION

#1058 ✅ Patent 11,324,800 granted on 2022-05-10
US20210338771A1
Human necessities

Aqueous suspensions of cyclosporin

#1059 ✅ Patent 11,612,636 granted on 2023-03-28
US20210338772A1
Human necessities

Method of treating autoimmune inflammatory crohn's disease

#1060
US20210338773A1
Human necessities

METHOD FOR TREATING RETINAL DEGENERATION DISEASE BY ADMINISTERING NUCLEOLIN POLYNUCLEOTIDE OR POLYPEPTIDE

#1061
US20210338774A1
Human necessities

PRG-4 FOR TREATING GOUT AND ITS SYMPTOMS

#1062
US20210338775A1
Human necessities

PREPARATION AND USE OF A PROTEIN-ENRICHED SOLUBLE FIBER COMPOSITION

#1063
US20210338776A1
Human necessities

TREATMENTS AGAINST MOSQUITO-BORNE VIRUSES BASED ON MOSQUITO SALIVARY GLAND PROTEINS

#1064
US20210338777A1
Human necessities

MODIFIED FIBROBLAST GROWTH FACTORS FOR THE TREATMENT OF OCULAR DISORDERS

#1065
US20210338778A1
Human necessities

METHODS FOR TREATMENT OF MICROBIAL DISORDERS

#1066
US20210338779A1
Human necessities

THERAPEUTIC USE OF GLUCAGON AND COMBINATION INCLUDING THE SAME

#1067
US20210338780A1
Human necessities

AVEXITIDE FOR THE TREATMENT OF HYPERINSULINEMIC HYPOGLYCEMIA

#1068 ✅ Patent 12,343,382 granted on 2025-07-01
US20210338781A1
Human necessities

METHODS OF USING A GIP/GLP1 CO-AGONIST FOR THERAPY

#1069
US20210338782A1
Human necessities

STORAGE STABLE SOMATOSTATIN-DOPAMINE CHIMERIC COMPOUNDS AND SALT FORMS THEREOF

#1070 ✅ Patent 12,161,701 granted on 2024-12-10
US20210338783A1
Human necessities

Compositions and methods for enzymatic disruption of bacterial biofilms

#1071
US20210338784A1
Human necessities

Botulinum Toxin Pharmaceutical Composition Comprising Tannic Acid

#1072
US20210338785A1
Human necessities

BLADDER INJECTION PARADIGM FOR ADMINISTRATION OF BOTULINUM TOXINS

#1073 ✅ Patent 11,975,056 granted on 2024-05-07
US20210338786A1
Human necessities

AADC polynucleotides for the treatment of Parkinson's disease

#1074
US20210338787A1
Human necessities

METHODS FOR TREATING CORONAVIRUS INFECTION

#1075 ✅ Patent 11,654,189 granted on 2023-05-23
US20210338788A1
Human necessities

Compositions and methods for enhancing the stability of transgenes in poxviruses

#1076
US20210338789A1
Human necessities

COMPOSITIONS AND METHODS FOR MODIFIED DENDRIMER NANOPARTICLE DELIVERY

#1077
US20210338790A1
Human necessities

INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES

#1078 ✅ Patent 12,186,382 granted on 2025-01-07
US20210338791A1
Human necessities

Immunogenic composition for paratuberculosis

#1079 ✅ Patent 11,918,637 granted on 2024-03-05
US20210338792A1
Human necessities

Vaccination against porcine circoviruses

#1080
US20210338793A1
Human necessities

PLASMIDS AND METHODS FOR PEPTIDE DISPLAY AND AFFINITY-SELECTION ON VIRUS-LIKE PARTICLES OF RNA BACTERIOPHAGES

#1081 ✅ Patent 12,357,682 granted on 2025-07-15
US20210338794A1
Human necessities

DNA PLASMID-LAUNCHED LIVE-ATTANUATED VACCINES FOR PLUS-SENSE SINGEL STRANDED RNA

#1082 ✅ Patent 11,376,318 granted on 2022-07-05
US20210338795A1
Human necessities

Methods of preparing anti-human papillomavirus antigen t cells

#1083 ✅ Patent 11,331,385 granted on 2022-05-17
US20210338796A1
Human necessities

Methods of preparing anti-human papillomavirus antigen T cells

#1084 ✅ Patent 11,338,032 granted on 2022-05-24
US20210338797A1
Human necessities

Methods of preparing anti-human papillomavirus antigen T cells

#1085 ✅ Patent 11,633,469 granted on 2023-04-25
US20210338798A1
Human necessities

Reassortant influenza virus production method

#1086 ✅ Patent 11,439,701 granted on 2022-09-13
US20210338799A1
Human necessities

Bovine respiratory disease vaccine

#1087
US20210338800A1
Human necessities

SIV AND HIV VACCINATION USING RHCMV- AND HCMV-BASED VACCINE VECTORS

#1088
US20210338801A1
Human necessities

INJECTABLE HYDROGELS FOR CONTROLLED RELEASE OF IMMUNOMODULATORY COMPOUNDS

#1089 ✅ Patent 11,305,007 granted on 2022-04-19
US20210338802A1
Human necessities

Composite multi-epitope expression cassette, a recombinant virus composed thereof and application thereof

#1090
US20210338803A1
Human necessities

DUAL-MOLECULAR DNA VACCINE COMPOSED OF A VIRAL ANTIGEN AND AN IMMUNE COSTIMULATOR

#1091 ✅ Patent 12,311,021 granted on 2025-05-27
US20210338804A1
Human necessities

Replication-competent attenuated chimeric VSV vectors encoding immunogenic SARS-CoV-2 spike proteins

#1092 ✅ Patent 12,150,984 granted on 2024-11-26
US20210338805A1
Human necessities

Dysregulation of trauma regulation pathway treatment and monitoring techniques

#1093
US20210338806A1
Human necessities

METHODS OF GENERATING VACCINES AGAINST NOVEL CORONAVIRUS, NAMED SARS-COV-2 COMPRISING VARIABLE EPITOPE LIBRARIES (VELs) AS IMMUNOGENS

#1094
US20210338807A1
Human necessities

COVID19 VACCINES AND RELATED METHODS

#1095
US20210338808A1
Human necessities

THERAPEUTIC VACCINE FOR THE TREATMENT OF PAPILLOMAVIRUS LESIONS

#1096
US20210338809A1
Human necessities

Immune Tolerance-Inducing Agent and Therapeutic or Prophylactic Agent for Allergic Disorder

#1097 ✅ Patent 11,896,666 granted on 2024-02-13
US20210338810A1
Human necessities

Adjuvant compositions

#1098
US20210338811A1
Human necessities

Combination Therapy of Immunotoxin and Checkpoint Inhibitor

#1099 ✅ Patent 11,931,412 granted on 2024-03-19
US20210338812A1
Human necessities

JAK1 inhibitors and uses thereof

#1100
US20210338813A1
Human necessities

Combination Therapy for Melanoma

#1101
US20210338814A1
Human necessities

COMBINATION OF IMMUNE EFFECTOR CELLS SPECIFIC FOR A TARGET ANTIGEN AND HEMATOPOIETIC CELLS THAT EXPRESS THE TARGET ANTIGEN IN AN ALTERED FORM

#1102
US20210338815A1
Human necessities

COMPOSITIONS AND METHODS FOR ENHANCING TRIPLEX AND NUCLEASE-BASED GENE EDITING

#1103 ✅ Patent 12,280,112 granted on 2025-04-22
US20210338816A1
Human necessities

Magnetic delivery system and hydrogel fixative for therapeutic cells

#1104
US20210338817A1
Human necessities

HEALING COMPOSITION COMPRISING ELECTROLYZED WATER

#1105 ✅ Patent 11,612,655 granted on 2023-03-28
US20210338818A1
Human necessities

Magnetic particle control and visualization

#1106
US20210338819A1
Human necessities

METHOD OF ADMINISTERING LOCAL ANESTHETIC SOLUTION FOR DENTAL AND/OR CONTRAST MEDIA USE

#1107
US20210338820A1
Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING ANTIEMETIC COMPOUNDS AND POLYORTHOESTER

#1108
US20210338821A1
Human necessities

Hydrogel Compositions

#1109
US20210338822A1
Human necessities

THERAPEUTIC EXOSOMES AND METHOD OF PRODUCING THEM

#1110 ✅ Patent 11,771,771 granted on 2023-10-03
US20210338823A9
Human necessities

Ceramide-like lipid-based delivery vehicles and uses thereof

#1111 ✅ Patent 11,364,300 granted on 2022-06-21
US20210338824A1
Human necessities

C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors

#1112
US20210338825A1
Human necessities

DEGRADERS OF HEPATITIS C VIRUS NS3/4A PROTEIN

#1113 ✅ Patent 12,239,712 granted on 2025-03-04
US20210338826A1
Human necessities

Combination therapy for the treatment of liver disease

#1114 ✅ Patent 12,005,122 granted on 2024-06-11
US20210338827A1
Human necessities

Compounds and methods for diagnosis and treatment of viral infections

#1115
US20210338828A1
Human necessities

DELIVERY CONSTRUCTS FOR TRANSCYTOSIS AND RELATED METHODS

#1116
US20210338829A1
Human necessities

INTERLEUKIN 10 CONJUGATES AND USES THEREOF

#1117 ✅ Patent 11,395,855 granted on 2022-07-26
US20210338830A1
Human necessities

Exon skipping oligomer conjugates for muscular dystrophy

#1118
US20210338831A1
Human necessities

ANTI-SEZ6 ANTIBODY DRUG CONJUGATES AND METHODS OF USE

#1119
US20210338832A1
Human necessities

Long Acting Multi-Specific Molecules And Related Methods

#1120
US20210338833A1
Human necessities

CHIMERIC ANTIGEN RECEPTOR-TARGETING LIGANDS AND USES THEREOF

#1121
US20210338834A1
Human necessities

DEGRADABLE HYALURONIC ACID HYDROGELS

#1122 ✅ Patent 11,951,178 granted on 2024-04-09
US20210338835A1
Human necessities

Methods for treating subjects suffering from acute myeloid leukemia with FLT3 ligand-targeted miR-150 nanoparticles

#1123
US20210338836A1
Human necessities

MULTI-SPECIFIC BINDING CONJUGATE, RELATED PHARMACEUTICAL COMPOSITIONS AND USE

#1124 ✅ Patent 11,596,698 granted on 2023-03-07
US20210338837A1
Human necessities

Synthetic polynucleotides encoding a human FKRP protein

#1125
US20210338838A1
Human necessities

GENE THERAPY FOR MACULAR DEGENERATION

#1126
US20210338839A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETIC RETINOPATHY

#1127 ✅ Patent 11,723,990 granted on 2023-08-15
US20210338840A1
Human necessities

Library of pH responsive polymers and nanoprobes thereof

#1128
US20210338841A1
Human necessities

Imaging Agents

#1129
US20210338842A1
Human necessities

DUAL-MODALITY NANOPROBE TARGETING GLIOBLASTOMA AND PREPARATION METHOD THEREOF

#1130
US20210338843A1
Human necessities

Co-Expression of Magnetotactic Bacterial Genes and Genes Encoding Iron Handling Proteins in Cells

#1131
US20210338844A1
Human necessities

METHODS FOR MAKING ULTRASOUND CONTRAST AGENTS

#1132 ✅ Patent 12,029,797 granted on 2024-07-09
US20210338845A1
Human necessities

Fatty acid derivative labeled with positron-emitting radionuclide

#1133
US20210338846A1
Human necessities

COMPETITIVE PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) BINDING AGENTS FOR REDUCTION OF NON-TARGET ORGAN UPTAKE OF RADIOLABELED PSMA INHIBITORS FOR PSMA POSITIVE TUMOR IMAGING AND RADIOPHARMACEUTICAL THERAPY

#1134
US20210338847A1
Human necessities

RADIOLABELLED COMPOUND OF A QUATERNARY AMMONIUM SALT OF A POLYCYCLIC AROMATIC AMINE AND METHODS OF MANUFACTURING AND DIAGNOSTIC USE THEREOF

#1135
US20210338848A1
Human necessities

COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING MACROPHAGE-RELATED DISORDERS USING CARBOHYDRATE-BASED MACROMOLECULAR CARRIER

#1136
US20210338849A1
Human necessities

COMPOUNDS AND COMPOSITIONS FOR THE DETECTION AND TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DISORDERS

#1137 ✅ Patent 11,712,485 granted on 2023-08-01
US20210338850A1
Human necessities

Triazine based radiopharmaceuticals and radioimaging agents

#1138 ✅ Patent 11,504,441 granted on 2022-11-22
US20210338851A1
Human necessities

Radiolabeled compounds targeting the prostate-specific membrane antigen

#1139 ✅ Patent 11,369,701 granted on 2022-06-28
US20210338852A1
Human necessities

Ri-labeled humanized antibody

#1140
US20210338853A1
Human necessities

PORTABLE FINGER DISINFECTION APPARATUS

#1141 ✅ Patent 11,554,187 granted on 2023-01-17
US20210338854A1
Human necessities

Remote pathogen eradication

#1142 ✅ Patent 11,707,541 granted on 2023-07-25
US20210338855A1
Human necessities

Pipette carousel with germicidal lamp

#1143 ✅ Patent 12,357,713 granted on 2025-07-15
US20210338856A1
Human necessities

INDUCTIVE HEATING SYSTEMS AND METHODS OF CONTROLLING THE SAME TO REDUCE BIOLOGICAL CARRYOVER

#1144 ✅ Patent 11,766,491 granted on 2023-09-26
US20210338857A1
Human necessities

Air-water-food-fabric-space-utility sanitizer

#1145
US20210338858A1
Human necessities

Money Disinfectant Machine

#1146 ✅ Patent 12,151,037 granted on 2024-11-26
US20210338859A1
Human necessities

Ultraviolet sterilization display device and control method thereof

#1147
US20210338860A1
Human necessities

ULTRAVIOLET (UV) LIGHT EMISSION DEVICE EMPLOYING VISIBLE LIGHT FOR OPERATION GUIDANCE, AND RELATED METHODS OF USE, PARTICULARLY SUITED FOR DECONTAMINATION

#1148 ✅ Patent 12,233,174 granted on 2025-02-25
US20210338861A1
Human necessities

System and method for reducing microbial load using violet light

#1149
US20210338862A1
Human necessities

SELF-STERILIZING TOUCHPOINTS FOR LIGHT ELECTRIC VEHICLES

#1150
US20210338863A1
Human necessities

DECONTAMINATION APPARATUS

#1151 ✅ Patent 12,208,171 granted on 2025-01-28
US20210338864A1
Human necessities

Ultraviolet disinfection and sanitizing systems and methods for electronic gaming devices and other gaming equipment

#1152 ✅ Patent 11,957,803 granted on 2024-04-16
US20210338865A1
Human necessities

Ultraviolet apparatus for food disinfection

#1153
US20210338866A1
Human necessities

ULTRAVIOLET (UV) LIGHT EMISSION DEVICE EMPLOYING UV LIGHT SOURCE HOUSING TO ACHIEVE UV LIGHT EMISSION IRRADIANCE UNIFORMITY

#1154
US20210338867A1
Human necessities

WEARABLE UV-C GLOVES FOR MICROBIAL DECONTAMINATION FROM SURFACES

#1155
US20210338868A1
Human necessities

PORTABLE GERMICIDAL APPARATUS FOR PROVIDING UVC RADIATION

#1156 ✅ Patent 12,151,042 granted on 2024-11-26
US20210338869A1
Human necessities

Sterilization system and method

#1157
US20210338870A1
Human necessities

GASEOUS DECONTAMINATION OF AIRCRAFT

#1158
US20210338871A1
Human necessities

STERILIZATION SYSTEM AND METHOD

#1159
US20210338872A1
Human necessities

Disinfecting Fogger

#1160 ✅ Patent 12,280,169 granted on 2025-04-22
US20210338873A1
Human necessities

Technologies for sanitizing medical devices

#1161 ✅ Patent 11,806,439 granted on 2023-11-07
US20210338874A1
Human necessities

Medical sterilization and storage cabinet with multidirectional access

#1162 ✅ Patent 11,376,342 granted on 2022-07-05
US20210338875A1
Human necessities

Miniature aromatherapy diffuser

#1163
US20210338876A1
Human necessities

Charging Device for Charging an Electrical Energy Store of a Motor Vehicle

#1164 ✅ Patent 12,083,256 granted on 2024-09-10
US20210338877A1
Human necessities

Integration of UV light into aircraft air management systems

#1165
US20210338878A1
Human necessities

UV LED Face Mask Attachment

#1166 ✅ Patent 12,194,205 granted on 2025-01-14
US20210338879A1
Human necessities

Multi-layer air filtration media with integrated disinfection capability

#1167 ✅ Patent 11,911,523 granted on 2024-02-27
US20210338880A1
Human necessities

Hemorrhage management system

#1168
US20210338881A1
Human necessities

ABSORBENT ANTIMICROBIAL WOUND DRESSINGS

#1169 ✅ Patent 12,059,504 granted on 2024-08-13
US20210338882A1
Human necessities

Method for the production of superabsorbents

#1170
US20210338883A1
Human necessities

FOAMED SKIN COMPATIBLE SILICONE COMPOSITION

#1171 ✅ Patent 11,590,257 granted on 2023-02-28
US20210338884A1
Human necessities

Antimicrobial hydrocolloid dressing containing sequestered peroxide and preparation thereof

#1172 ✅ Patent 11,896,733 granted on 2024-02-13
US20210338885A1
Human necessities

Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds

#1173 ✅ Patent 12,102,731 granted on 2024-10-01
US20210338886A1
Human necessities

Port-accessible multidirectional reinforced minimally invasive collagen device for soft tissue repair

#1174
US20210338887A1
Human necessities

SYSTEMS FOR TARGETED TISSUE BIOSEALING OR REPAIR

#1175
US20210338888A1
Human necessities

ANTIMICROBIAL IMPLANT COATING

#1176
US20210338889A1
Human necessities

IMPLANT WITH CERAMIC COATING, METHOD OF FORMING AN IMPLANT, AND METHOD OF APPLYING A CERAMIC COATING

#1177
US20210338890A1
Human necessities

MENISCUS REGENERATION MATERIAL

#1178
US20210338891A1
Human necessities

DECELLULARIZATION OF TISSUES USING SUPERCRITICAL CARBON DIOXIDE

#1179
US20210338892A1
Human necessities

AUTOMATED METHOD FOR TREATING A BIOLOGICAL TISSUE IN ORDER TO PRODUCE A TISSUE MATRIX

#1180
US20210338893A1
Human necessities

BIOLOGIC TISSUE PROCESSING DEVICE

#1181
US20210338894A1
Human necessities

Artificial Periosteum

#1182
US20210338895A1
Human necessities

Bioactive bone repair particles

#1183
US20210338896A1
Human necessities

METHOD FOR PRODUCING A MATERIAL FOR A BONE IMPLANT

#1184
US20210338897A1
Human necessities

VASCULAR DEVICE AND METHOD FOR MANUFACTURING A VASCULAR DEVICE

#1185
US20210338898A1
Human necessities

CONTROLLED RANDOMIZED POROUS STRUCTURES AND METHODS FOR MAKING SAME

#1186
US20210338899A1
Human necessities

CONTROLLED RANDOMIZED POROUS STRUCTURES AND METHODS FOR MAKING SAME

#1187
US20210338900A1
Human necessities

CONTROLLED RANDOMIZED POROUS STRUCTURES AND METHODS FOR MAKING SAME

#1188 ✅ Patent 12,285,547 granted on 2025-04-29
US20210338901A1
Human necessities

Controlled randomized porous structures and methods for making same

#1189
US20210338902A1
Human necessities

CONTROLLED RANDOMIZED POROUS STRUCTURES AND METHODS FOR MAKING SAME

#1190 ✅ Patent 11,918,707 granted on 2024-03-05
US20210338903A1
Human necessities

Implant, preferably for the treatment of an acetabular defect

#1191
US20210338904A1
Human necessities

FIBROUS MEMBRANE MATERIAL FOR SOFT TISSUE REPAIR, METHOD FOR PREPARING THE SAME, AND APPLICATION THEREOF

#1192
US20210338905A1
Human necessities

A MEDICAL TUBULAR DEVICE

#1193 ✅ Patent 11,744,926 granted on 2023-09-05
US20210338906A1
Human necessities

Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications

#1194
US20210338907A1
Human necessities

Preparation of fibroin and therapeutic products made thereof

#1195 ✅ Patent 11,738,125 granted on 2023-08-29
US20210338908A1
Human necessities

Systems and methods for estimating ultrafiltration rates

#1196 ✅ Patent 11,590,271 granted on 2023-02-28
US20210338909A1
Human necessities

Easily movable blood purification systems

#1197
US20210338910A1
Human necessities

Dialysis Device for Use with Interface Media, Dialysis Systems, Use of Dialysis Device, Method for Establishing Dialysis System, Method for Filling and/or Priming Dialysis System and Method for Removing Air from Dialysis System

#1198
US20210338911A1
Human necessities

A DEVICE AND SYSTEM PROVIDING A MEDICAL SOLUTION AND A METHOD THEREOF

#1199 ✅ Patent 12,161,788 granted on 2024-12-10
US20210338912A1
Human necessities

Fluid circuits for sorbent cartridges with sensors

#1200 ✅ Patent 11,607,479 granted on 2023-03-21
US20210338913A1
Human necessities

Optimizing peritoneal dialysis using a patient hand-held scanning device